Hasegawa Y - Search Results

1

Clinical impact of cachexia in unresectable locally advanced head and neck cancer: supplementary analysis of a phase II trial (JCOG0706-S2).

Matsuzuka T, Kiyota N, Mizusawa J, Akimoto T, Fujii M, Hasegawa Y, Iwae S, Monden N, Matsuura K, Onozawa Y, Hayashi R, Tahara M; Japan Clinical Oncology Group(JCOG) Head and Neck Cancer Study Group. Matsuzuka T, et al. Among authors: hasegawa y. Jpn J Clin Oncol. 2019 Jan 1;49(1):37-41. doi: 10.1093/jjco/hyy145. Jpn J Clin Oncol. 2019. PMID: 30364985 Clinical Trial.

2

[Chemo-radiotherapy for head and neck cancer].

Hasegawa Y. Hasegawa Y. Gan To Kagaku Ryoho. 2002 May;29(5):677-83. Gan To Kagaku Ryoho. 2002. PMID: 12040670 Review. Japanese.

3

Prognostic significance of late cervical metastasis and distant failure in patients with stage I and II oral tongue cancers.

Goto M, Hasegawa Y, Terada A, Hyodo I, Hanai N, Ijichi K, Yamada H, Fujimoto Y, Ogawa T. Goto M, et al. Among authors: hasegawa y. Oral Oncol. 2005 Jan;41(1):62-9. doi: 10.1016/j.oraloncology.2004.06.007. Oral Oncol. 2005. PMID: 15598587

4

[A Phase I study of docetaxel and cisplatin for advanced squamous cell carcinoma of the head and neck].

Ogawa T, Terada A, Hyodo I, Ando A, Suzuki Y, Ozawa T, Hasegawa Y. Ogawa T, et al. Among authors: hasegawa y. Gan To Kagaku Ryoho. 2005 Jul;32(7):977-81. Gan To Kagaku Ryoho. 2005. PMID: 16044959 Clinical Trial. Japanese.

5

Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.

Hasegawa Y, Goto M, Hanai N, Ijichi K, Adachi M, Terada A, Hyodo I, Ogawa T, Furukawa T. Hasegawa Y, et al. Oral Oncol. 2007 Sep;43(8):749-56. doi: 10.1016/j.oraloncology.2006.09.003. Epub 2006 Nov 16. Oral Oncol. 2007. PMID: 17112769

6

[Long-term results of S-1 administration as adjuvant chemotherapy for advanced head and neck cancer].

Tsukuda M, Kida A, Fujii M, Kono N, Yoshihara T, Hasegawa Y, Sugita M. Tsukuda M, et al. Among authors: hasegawa y. Gan To Kagaku Ryoho. 2007 Aug;34(8):1215-25. Gan To Kagaku Ryoho. 2007. PMID: 17687202 Japanese.

7

Prediction of chemosensitivity using multigene analysis in head and neck squamous cell carcinoma.

Hasegawa Y, Goto M, Hanai N, Ijichi K, Terada A, Hyodo I, Ogawa T, Fukushima M. Hasegawa Y, et al. Oncology. 2007;73(1-2):104-11. doi: 10.1159/000120998. Epub 2008 Mar 13. Oncology. 2007. PMID: 18337622

8

Total microvessel perimeter per tumor area is a predictor of radiosensitivity in early-stage glottic carcinoma.

Zhang S, Hayashi R, Fujii M, Hasegawa Y, Yoshino K, Fukayama M, Ochiai A. Zhang S, et al. Among authors: hasegawa y. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1104-9. doi: 10.1016/j.ijrobp.2008.05.038. Epub 2008 Oct 22. Int J Radiat Oncol Biol Phys. 2009. PMID: 18950960

9

[A Phase II study of docetaxel and cisplatin in patients with recurrent or unresectable squamous cell carcinoma of the head and neck].

Hanai N, Terada A, Ozawa T, Hirakawa H, Yokoi H, Hasegawa Y. Hanai N, et al. Among authors: hasegawa y. Gan To Kagaku Ryoho. 2009 Aug;36(8):1281-5. Gan To Kagaku Ryoho. 2009. PMID: 19692766 Clinical Trial. Japanese.

10

Long-term follow-up and a detailed prognostic analysis of patients with oropharyngeal cancer treated with radiotherapy.

Tomita N, Kodaira T, Furutani K, Tachibana H, Hasegawa Y, Terada A, Hanai K, Ozawa T, Nakamura T, Fuwa N. Tomita N, et al. Among authors: hasegawa y. J Cancer Res Clin Oncol. 2010 Apr;136(4):617-23. doi: 10.1007/s00432-009-0700-7. Epub 2009 Oct 27. J Cancer Res Clin Oncol. 2010. PMID: 19859735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,803 results

Search Page

Filters